CT
Contineum Therapeutics, Inc. (CTNM)
NASDAQ·Healthcare·Biotechnology
$13.90
+1.89%
Mkt Cap $557.54M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
+15.1%
Consensus $16.00 vs current $13.90
NASDAQ·Healthcare·Biotechnology
$13.90
+1.89%
Mkt Cap $557.54M
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$16.00
Range $16.00 – $16.00
+15.1%
Consensus $16.00 vs current $13.90